COVID-19

Benign Hematology

Questions discussed in this category

Is rituximab for refractory ITP contraindicated in the setting of an active COVID infection, particularly in a patient with asymptomatic COVID?

2 Answers available

In a patient with a bleeding disorder, how would one approach anticoagulation during active COVID infection?

Bleeding disorder such as vWD

1 Answer available

How have you been counseling patients with sickle cell regarding a 3rd COVID vaccine?

3 Answers available

Should we recommend the COVID-19 booster vaccine to patients who had a DVT or any other complications such as hemolytic anemia or thrombocytopenia from prior vaccine doses?

2 Answers available

In a patient with a heterozygous prothrombin gene mutation who has COVID with minimal symptoms, do you recommend prophylactic and/or therapeutic anticoagulation?

1 Answer available

Do you routinely check platelet counts after COVID-19 vaccines in patients with chronic ITP?

1 Answer available

Do you recommend COVID vaccination in patients with antiphospholipid antibody positivity or other prothrombotic states not on anti-coagulation?

1 Answer available

What hematologic conditions are contraindications for a COVID vaccine?

2 Answers available

In which patients with oncologic or hematologic disorders are you recommending a 3rd dose of mRNA COVID vaccine?

2 Answers available

How do you advise a patient with VTE on indefinite anticoagulants regarding the Ad26.COV2.S Johnson & Johnson/Janssen COVID vaccine?

1 Answer available

How would you advise patients with known stable autoimmune thrombocytopenia regarding the Ad26.COV2.S (Johnson & Johnson/Janssen) vaccine?

1 Answer available

What are the current official guidelines regarding COVID-19 vaccination for patients with cancer or for hematologic conditions?

2 Answers available

Papers discussed in this category

Blood,

Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance.

N Engl J Med, 2021 Apr 14

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination.

Ann Oncol, 2021 Mar 18

Association of Clinical Factors and Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium.

Semin Hematol,

Epidemiology and risk factors for venous thrombosis.

Am J Hematol, 2021 Jun 29

BNT162b2 COVID-19 vaccine is significantly less effective in patients with hematologic malignancies.

Blood, 2010-11-04

Severe pandemic H1N1 and seasonal influenza in children and young adults with sickle cell disease.

Pediatric blood & cancer, 2014-05

Respiratory syncytial virus and seasonal influenza cause similar illnesses in children with sickle cell disease.

British journal of haematology, 2015-05

Immune parameter analysis of children with sickle cell disease on hydroxycarbamide or chronic transfusion therapy.

Oman Med J, 2020 Nov 07

Respiratory Viral Infections in Sickle Cell Anemia: Special Emphasis on H1N1 Co-infection.

Pediatr Blood Cancer, 2020 Sep 08

Fatal viral infections in hemoglobin sickle cell C patients.

Blood Adv,

COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals.

Hemoglobin, 2021 May 24

Incidence Rate of COVID-19 Infection in Hemoglobinopathies: A Systematic Review and Meta-analysis.

Thromb Res, 2021 Jun 25

Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study.

Related Topics in COVID-19